Selectis Health, Inc NT 10-Q, filed Aug 8, 2023
Selectis Health, Inc. (GBCS)
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
SEC File Number 0-15415
CUSIP Number 816291108
NOTICE OF LATE FILING
(Check One):
☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR
For Period Ended: June 30, 2023
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A
Part I—Registrant Information
| Full Name of Registrant: | Selectis Health, Inc. |
Former Name if Applicable:
Address of Principal Executive Office (Street and Number):
8480 E. Orchard Road, Ste. 4900
Greenwood Village, CO 80111
| Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Part II—Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12(b)-25(b), the following should be completed. (Check box if appropriate)
| (a) | ☐ | The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| (b) | ☒ | The subject annual report or semi-annual report/portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report/portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and |
| (c) | ☐ | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
Part III—Narrative
State below in reasonable detail the reasons why form 10-K, 11-K, 20-F, 10-Q or N-SAR or portion thereof could not be filed within the prescribed time period.
The Registrant is unable to file its Quarterly Report on Form 10-Q within the prescribed time period because the Company has not completed the preparation of its unaudited financial statements for the fiscal quarter.
Part IV—Other Information
(1) Name and telephone number of person to contact in regard to this notification
Clifford L. Neuman, P.C.
6800 N. 79th Street, Ste. 200
Niwot, Colorado 80503
(303) 449-2100
(2) Have all other period reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
The Registrant’s 10-K for FYE 12/31/22 has yet to be filed.
☒ Yes ☐ No
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
☐ Yes ☒ No
If so; attach an explanation of the anticipated change, both narratively and quantitively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
SELECTIS HEALTH, INC.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
| Date: August 8, 2023 | By: | /s/ Lance Baller |
| Lance Baller, CEO |